跳至主要内容
临床试验/CTRI/2023/02/049758
CTRI/2023/02/049758尚未招募未知

Tacrolimus dose optimization in pre and post renal transplant patients with high hepatic drug metabolism(CYP4503A5 polymorphic genotype) by therapeutic drug monitoring

IQRAA INTERNATIONAL HOSPITAL AND RESEARCH CENTER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • First objective- All pre and post-renal transplant patients willing to participate in the study.
  • Second objective- patients found to be extensive metabolizer for tacrolimus on genotyping.

排除标准

  • Patients not willing/cooperative for the study. Patients who are on other drugs which interfere with the tacrolimus level. Patients with abnormal LFT and patients who are not available for follow up.

研究者

发起方
IQRAA INTERNATIONAL HOSPITAL AND RESEARCH CENTER

相似试验

A clinical trial to adjust the dose of Tacrolimus in... | 临床试验